Fig. 2.
Fig. 2. (A) Southern blot analysis of DNA digested with BamHI and probed with a 1.4-kb BamHI fragment of p300 cDNA probe. As a control, normal peripheral lymphocytes were used (lane 1). The patient exhibits rearranged bands (arrowhead), suggesting that a 1.4-kb BamHI fragment of p300 cDNA spans the translocation breakpoint (lane 2). (B) The same blot was rehybridized with the 0.9-kb BamHI fragment of MLL cDNA (probe x). The patient exhibits rearranged bands the same size as the bands detected with a BamHI fragment of p300 cDNA (arrowhead), suggesting that probe × also spans the breakpoint and that the p300 gene is translocated to the MLL gene. (C) Northern blot of RNAs using a 1.5-kb BamHI fragment of p300 cDNA probe. As a control, normal peripheral lymphocytes were used (lane 1). The patient showed an additional transcript (arrowhead) of approximately 11.5 kb (lane 2). (D) The same blot was rehybridized with the 0.9-kb BamHI fragment of MLL cDNA (probe x). The patient exhibits an aberrant band the same size as the band detected with a BamHI fragment of p300 cDNA (arrowhead). (E) Western blot analysis using p300-specific antibody against the C-terminal of p300. As a control, Namalwa, a Burkitt lymphoma cell line, was used (lane 1). The patient showed an additional polypeptide (arrowhead) of approximately 350 kD (lane 2).

(A) Southern blot analysis of DNA digested with BamHI and probed with a 1.4-kb BamHI fragment of p300 cDNA probe. As a control, normal peripheral lymphocytes were used (lane 1). The patient exhibits rearranged bands (arrowhead), suggesting that a 1.4-kb BamHI fragment of p300 cDNA spans the translocation breakpoint (lane 2). (B) The same blot was rehybridized with the 0.9-kb BamHI fragment of MLL cDNA (probe x). The patient exhibits rearranged bands the same size as the bands detected with a BamHI fragment of p300 cDNA (arrowhead), suggesting that probe × also spans the breakpoint and that the p300 gene is translocated to the MLL gene. (C) Northern blot of RNAs using a 1.5-kb BamHI fragment of p300 cDNA probe. As a control, normal peripheral lymphocytes were used (lane 1). The patient showed an additional transcript (arrowhead) of approximately 11.5 kb (lane 2). (D) The same blot was rehybridized with the 0.9-kb BamHI fragment of MLL cDNA (probe x). The patient exhibits an aberrant band the same size as the band detected with a BamHI fragment of p300 cDNA (arrowhead). (E) Western blot analysis using p300-specific antibody against the C-terminal of p300. As a control, Namalwa, a Burkitt lymphoma cell line, was used (lane 1). The patient showed an additional polypeptide (arrowhead) of approximately 350 kD (lane 2).

Close Modal

or Create an Account

Close Modal
Close Modal